How would your patients benefit from our multifocal IOLs?
6 months after binocular implantation of M-flex +3.0 D:
% patients with functional vision without the need for spectacles 14
90%
for distance vision
for distance vision
80%
for intermediate vision
for intermediate vision
70%
for near vision
for near vision
98%
of patients were subjectively satisfied with outcomes
of patients were subjectively satisfied with outcomes
At 12 month follow up NO patients reported dysphotopic phenomena
M-flex
M-flex Multifocal IOLs offer your presbyopic patients the chance of spectacle independence for distance, intermediate and near activities. 14
Select the correct multifocal option to match your patient's lifestyle:
- M-flex +3.0 D add for patients that predominantly participate in intermediate and distance activities
i.e. intermediate activities such as computer work or seeing a vehicle dashboard - M-flex +4.0 D add for patients that predominantly participate in near and distance activities
i.e. near activities such as reading or applying make-up
Intermediate visual acuity improved post-surgery without compromising distance or near vision15
References:
- Cezón Prieto J and Bautista MJ. JCRS 2010; 36:1508-1516.
- Rasilber T et al. J Cataract Refract Surg 2013; 39: 350-557.
M-flex T
Wouldn't your presbyopic, astigmatic patients also like the opportunity to live without glasses?
With M-flex T Multifocal Toric IOLs, patients with astigmatism need no longer be excluded from the lifestyle advantages of multifocality.
M-flex T offers all the benefits of the M-flex and effectively corrects corneal astigmatism with a large range of cylinder power options (1 to 6 Dioptres)
Both M-flex and M-flex T IOLs are supplied with a Rayner injector
- Uniquely designed loading bay with an extension "lip" to facilitate loading.
- Soft plunger tip completely fills the nozzle and offers a soft protective interface with the IOL.
- Syringe-style design for single-handed technique for smooth IOL delivery with predictable and efficient insertion, ensuring consistent IOL implantations.
- Sterile Single-Use, ready to use.
| Model Name: | M-flex |
| Model Number: | 580F / 630F |
| Power Range: |
+3.0 D 附加光焦度 +4.0 D 附加光焦度 |
| Optic Diameter: | 5.75 mm (580F) / 6.25 mm (630F) |
| Overall Length: | 12.00 mm (580F) / 12.50 mm (630F) |
| Model Name: | M-flex T |
| Model Number: | 588F / 638F |
| Power Range: |
Sphere: +14.0 to +32.0 D (0.5 D increments) Cylinder: +1.0 to +6.0 D (0.5 D increments) |
| Optic Diameter: | 5.75 mm (588F) / 6.25 mm (638F) |
| Overall Length: | 12.00 mm (588F) / 12.50 mm (638F) |
| 推注系统 | |
| 推注器类型： | 一次性使用，手动安装 |
| 喷嘴直径： | 2.00 mm |
| 喷嘴斜面角度： | 45° |
| 人工晶体推送方式： | 单手植入 |
| 非球面多焦点人工晶体 | |
| 材料： | Rayacryl® 亲水丙烯酸 |
| 含水量： | 26% |
| 紫外线防护： | 紫外线吸收剂 |
| 紫外线透过率： | UV 10% (380 nm) |
| 屈光指数： | 1.46 |
| 光学部形状： | 双凸 (正度数), 双凹 (负度数) |
| 非球面技术： | 前表面非球面技术处理，零球差 |
| 光学部边缘设计： | Amon-Apple 360° 360° 完全方边 |
| 襻夹角： | 0° |
| 襻形： | Closed loop with anti-vaulting haptic (AVH) technology |
| Estimated constants for optical biometry SRK/T: | 118.6 |
| Estimated constants for Ultrasound A-constant: | 118.0 |
*Please note that the constants indicated for all Rayner lenses are estimates and are for guidance purposes only. Surgeons must always expect to personalise their own constants based on initial patient outcomes, with further personalisation as the number of eyes increases.
不是所有产品都提供给每一个市场。每个国家和地区标签和说明书各不相同。如需要有特殊要求的产品信息请联系当地代理商或发邮件至 sales@rayner.com.cn。
Superflex没有获得美国FDA经营许可如需了解C-flex在美国FDA的状态请联系法规部门。
Rayner所有产品均拥有CE证书，请联系法规部门索取。
Manually Loaded Primary IOL Platform
The importance of a high-performance platform.
For over sixty years Rayner has created IOLs with a simple guiding design principle; that our products do not just restore clear vision, but go further - to exceed the expectations of both cataract patient and surgeon.
Characterised by accurate, predictable, and sustainable refractive outcomes supported by 10 years of positive clinical data and the world’s longest commercial history of IOL design & manufacturing, the C-flex platform is one of the highest quality and best-designed monofocal IOLs on the market.
Today, the Rayner primary IOL range continues to deliver on our promise, with an innovative portfolio of monofocal, toric and multifocal IOLs based on this single, proven platform
When considering an intraocular lens, what's important to you ?
Click on + below to see the features and benefits of the Rayner Primary Platform.
X
Optimal visual quality in all lighting conditions
Aspheric optic technology reduces spherical aberration:3,4
- Excellent contrast sensitivity and retained depth of field from aberration-neutral aspheric optic3,4
- Available in two optic sizes; 5.75mm or 6.25mm
X
An IOL free from vacuoles and glistenings8
- Single piece IOLs created from Rayacryl®
- Compressible material for delivery through a small incision
- Excellent handling characteristics with controlled unfolding within the capsular bag
- Low silicone oil adherence9
- Excellent uveal biocompatibility16
- Hydrophilic acrylic material with low inflammatory response10
- Low refractive index (1.46) linked to low incidence of glare and external reflections17
X
Peace of mind with low rates of posterior capsular opacification (PCO)
Rayner's 360° Amon-Apple Enhanced Square Edge creates a physical barrier to prevent epithelial cell migration7
| ND:YAG CAPSULOTOMY RATES7 | MEAN TIME TO ND:YAG CAPSULOTOMY7 | |
| At 12 months | 0.6% |
9.3 ± 5.5 months
Follow-up period: 5.3 – 29 months |
| At 24 months | 1.7% | |
Study of 3,461 patients receiving Rayner C-flex 570C IOLs over a 24 month period, Nd:YAG capsulotomy rates were extremely low and comparable with hydrophobic acrylic lenses with square-edge optics.7
X
Reliable optical outcomes and a low rate of post-operative complications
Rayner's Anti-Vaulting Haptic (AVH) Technology® provides proven rotational and centrational stability, and excellent fixation in the capsular bag1
- Superb centration
– Maximum offset of only 1mm 3 months after surgery2 - Excellent rotational and torsional stability2
References:
- 1. Claoué C. Clinical and Surgical Ophthalmology 2008; 26(6): 198-200
- 2. Alberdi R et al. J Refract Surg. 2012; 28(10):696-700
- 3. Nanavaty MA et al. J Cataract Refract Surg. 2009; 35:663–671
- 4. Yagci R et al. Eur J Ophthalmol. 2014 Jul 24; 24(5):688-92
- 7. Mathew RG and Coombes AGA. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec; 41(6):651-5
Scientific Papers and Supporting Materials
Peer Review Papers
- Gangwani V, Hirnschall N, Findl O, Maurino V. Multifocal toric intraocular lenses versus multifocal intraocular lenses combined with peripheral corneal relaxing incisions to correct moderate astigmatism. J Cataract Refract Surg. 2014 Oct;40(10):1625-32.
- Shimoda T, Shimoda G, Hida WT, Nakano CT, Motta AF, Guimarães AS, Tzelikis PFM, Visual outcomes after implantation of a novel refractive toric multifocal intraocular lens. Arq Bras Oftalmol. 2014 Apr;77(2):71-5
- Rabsilber TM, Rudalevicius P, Jasinskas V, Holzer MP, Auffarth GU. Influence of +3.00 D and +4.00 D near addition on functional outcomes of a refractive multifocal intraocular lens model. J Cataract Refract Surg. 2013 Mar;39(3):350-7
- Agresta B, Knorz MC, Kohnen T, Donatti C, Jackson D.Distance and near visual acuity improvement after implantation of multifocal intraocular lenses in cataract patientswith presbyopia: a systematic review. J Refract Surg. 2012 Jun;28(6):426-35
- Cezón Prieto J, Bautista MJ. Visual outcomes after implantation of a refractive multifocal intraocular lens with a +3.00 D addition. J Cataract Refract Surg. 2010 Sep;36(9):1508-16
Trade papers
RAYTRACE
OVDs
